PRLD Prelude Therapeutics Incorporated - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$3,67
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,15rendah 52m
$6,83tinggi 52m
P/E (TTM)
-5.0
EPS (TTM)
$-0.73
Pendapatan (TTM)
$22M
lencana Anda
Rentang 52M
$1–$7
Peringkat Analis
BUY
Target Harga
$9
P/E
-5.0
ROE
-57.7%
Margin Laba Bersih
-269.7%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PRLD Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$3.67
P/E (TTM)
-5.0
EPS (TTM)
$-0.73
Pendapatan (TTM)
$22M
ROE (TTM)
-57.7%
Rentang 52M
$1–$7
PRLD Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$12M2024-12-31 → 2025-12-31
EPS$-1.292021-12-31 → 2025-12-31
Arus Kas Bebas$-56M2020-12-31 → 2025-12-31
Margin bersih-269.7%2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PRLD | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -5.0rata-rata 5T ≈-2.5 | ≈-2.5 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PRLD | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -300.6% | · | -123.1% | Lemah | |
| Margin EBITDA (TTM) | -293.5% | · | -123.1% | Lemah | |
| Margin Laba Bersih (TTM) | -269.7% | · | -150.6% | Lemah | |
| ROA (TTM) | -39.8%rata-rata 5T ≈-50.8% | ≈-50.8% | -43.8% | Lemah | |
| ROE (TTM) | -57.7%rata-rata 5T ≈-74.1% | ≈-74.1% | -115.5% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PRLD | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 4.1rata-rata 5T ≈8.6 | ≈8.6 | 5.6 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 1.9rata-rata 5T ≈8.5 | ≈8.5 | 5.0 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | PRLD | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 73.4% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | PRLD | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.1 | · | 0.2 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$153.7K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-74.3%
Laporan Berikutnya
Nov 10, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 19, 2026 | $-0.14 | $-0.20 | 30.2% |
| 31 Maret 2026 | Mei 12, 2026 | $-0.13 | $-0.25 | 48.7% |
| 31 Des. 2025 | $-0.20 | $-0.03 | -575.7% | |
| 30 Sep. 2025 | $-0.26 | $-0.37 | 30.2% | |
| 30 Juni 2025 | $-0.41 | $-0.45 | 8.5% | |
| 31 Maret 2025 | $-0.42 | $-0.48 | 12.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue | $12M | $7M | |
| R&D Expense | $94M | $118M | |
| SG&A Expense | $22M | $29M | |
| Operating Expenses | $117M | $147M | |
| Operating Income | $-105M | $-140M | |
| Other Non-op | $5M | $13M | |
| Income Tax | $0 | $0 | |
| Net Income | $-99M | $-127M | |
| EPS (Basic) | $-1.29 | $-1.68 | |
| EPS (Diluted) | $-1.29 | $-1.68 | |
| Shares (Basic) | 76,956,194 | 75,805,840 | |
| Shares (Diluted) | 76,956,194 | 75,805,840 | |
| EBITDA | $-103M | $-138M |
Neraca
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $35M | $12M | |
| Short-term Investments | $68M | $121M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $106M | $136M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $12M | $12M | |
| Accum. Depreciation | $7M | $5M | |
| Total Assets | $141M | $176M | |
| Accounts Payable | $4M | $8M | |
| Accrued Liabilities | $13M | $15M | |
| Current Liabilities | $53M | $26M | |
| Capital Leases | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | |
| Total Liabilities | $73M | $44M | |
| Retained Earnings | $-683M | $-584M | |
| AOCI | $8.0K | $35.0K | |
| Stockholders' Equity | $69M | $131M | |
| Liabilities + Equity | $141M | $176M |
Arus Kas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $2M | |
| Stock-based Comp | $12M | $21M | |
| Restructuring | $1M | · | |
| Other Non-cash | $30M | $1M | |
| Operating Cash Flow | $-56M | $-103M | |
| CapEx | $67.0K | $764.0K | |
| Investing Cash Flow | $53M | $90M | |
| Financing Cash Flow | $25M | $-120.0K | |
| Net Change in Cash | $22M | $-13M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-56M | $-104M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -861.3% | -1995.9% | |
| Net Margin | -819.6% | -1816.8% | |
| EBITDA Margin | -847.2% | -1970.6% | |
| ROA | -62.8% | -56.1% | |
| ROE | -137.7% | -88.3% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.0 | 5.3 | |
| Quick Ratio | 1.9 | 5.2 |
Efisiensi
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 |
Per Saham
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue / Share | $0.16 | $0.09 | |
| Cash Flow / Share | $-0.73 | $-1.36 | |
| EPS (TTM) | $-1.29 | $-1.68 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 73.4% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $12M | $7M | |
| Net Income TTM | $-99M | $-127M | |
| P/E | -2.2 | -0.8 | |
| Earnings Yield | -44.5% | -131.8% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $5M | $6M | $6M | $0 | $0 | $4M | $3M | |
| R&D Expense | $16M | $14M | $18M | $22M | $26M | $29M | $32M | $29M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $8M | |
| Operating Expenses | $21M | $19M | $23M | $27M | $32M | $35M | $38M | $37M | |
| Operating Income | $-15M | $-14M | $-17M | $-20M | $-32M | $-35M | $-34M | $-34M | |
| Other Non-op | $2M | $4M | $891.0K | $693.0K | $963.0K | $3M | $5M | $2M | |
| Net Income | $-14M | $-10M | $-16M | $-20M | $-31M | $-32M | $-29M | $-32M | |
| EPS (Basic) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| EPS (Diluted) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| Shares (Basic) | 98,388,593 | 82,519,981 | · | 76,132,337 | 75,993,941 | 75,986,281 | · | 75,855,949 | |
| Shares (Diluted) | 98,388,593 | 82,519,981 | · | 76,132,337 | 75,993,941 | 75,986,281 | · | 75,855,949 | |
| EBITDA | $-15M | $-14M | · | $-20M | $-32M | $-34M | · | $-34M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $22M | $35M | $48M | $26M | $40M | $12M | $11M | |
| Short-term Investments | $125M | $60M | $68M | $7M | $47M | $59M | $121M | $142M | |
| Prepaid Expense | $3M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | |
| Current Assets | $155M | $85M | $106M | $58M | $77M | $102M | $136M | $156M | |
| PP&E (Net) | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | · | · | $12M | · | · | · | $12M | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | |
| Total Assets | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M | |
| Accounts Payable | $2M | $2M | $4M | $3M | $5M | $6M | $8M | $6M | |
| Accrued Liabilities | $8M | $6M | $13M | $13M | $13M | $11M | $15M | $14M | |
| Current Liabilities | $38M | $42M | $53M | $18M | $21M | $20M | $26M | $22M | |
| Capital Leases | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Liabilities | $56M | $59M | $73M | $36M | $39M | $38M | $44M | $41M | |
| Retained Earnings | $-707M | $-693M | $-683M | $-667M | $-647M | $-616M | $-584M | $-555M | |
| AOCI | $-227.0K | $-41.0K | $8.0K | $2.0K | $-1.0K | $12.0K | $35.0K | $167.0K | |
| Stockholders' Equity | $134M | $60M | $69M | $59M | $76M | $103M | $131M | $156M | |
| Liabilities + Equity | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $353.0K | $391.0K | $418.0K | $425.0K | $433.0K | $435.0K | $489.0K | $405.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $6M | |
| Restructuring | $0 | $0 | $851.0K | $0 | · | · | · | · | |
| Other Non-cash | · | $-14M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-16M | $-22M | $23M | $-19M | $-26M | $-34M | $-21M | $-27M | |
| CapEx | $0 | $0 | $0 | $0 | $20.0K | $47.0K | $53.0K | $63.0K | |
| Investing Cash Flow | $-66M | $8M | $-60M | $40M | $12M | $62M | $22M | $11M | |
| Financing Cash Flow | $86M | $-314.0K | $25M | $-5.0K | $37.0K | $-160.0K | $-34.0K | $-131.0K | |
| Net Change in Cash | $5M | $-14M | $-12M | $21M | $-15M | $28M | $1M | $-17M | |
| Free Cash Flow | · | $-22M | · | · | · | $-34M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -270.9% | -309.5% | · | -314.1% | · | · | · | -1145.9% | |
| Net Margin | -244.1% | -226.8% | · | -303.5% | · | · | · | -1075.7% | |
| EBITDA Margin | -270.9% | -301.0% | · | -314.1% | · | · | · | -1145.9% | |
| ROA | -9.2% | -8.0% | · | -13.5% | -18.4% | -16.5% | · | -14.2% | |
| ROE | -13.3% | -12.7% | · | -18.4% | -24.2% | -20.4% | · | -16.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 2.0 | · | 3.2 | 3.7 | 5.2 | · | 7.0 | |
| Quick Ratio | 4.0 | 2.0 | · | 3.0 | 3.5 | 5.0 | · | 6.9 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.06 | $0.06 | · | $0.09 | · | · | · | $0.04 | |
| Cash Flow / Share | · | $-0.26 | · | · | · | $-0.45 | · | · | |
| EPS (TTM) | $-0.73 | $-1.00 | · | $-1.46 | $-1.63 | $-1.68 | · | $-1.76 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $17M | · | $10M | $7M | · | · | · | |
| Net Income TTM | $-60M | $-78M | · | $-112M | $-124M | $-128M | · | $-132M | |
| P/E | -7.3 | -3.4 | · | -1.0 | -0.5 | -0.5 | · | -1.2 | |
| Earnings Yield | -13.7% | -29.2% | · | -101.4% | -201.5% | -218.8% | · | -85.0% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $12M | $7M | · | · | · |
| Margin Operasi % | -861.3% | -1995.9% | · | · | · |
| Laba Bersih | $-99M | $-127M | $-122M | $-115M | $-112M |
| EPS Dilusian | $-1.29 | $-1.68 | $-2.02 | $-2.44 | $-2.43 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 2.0 | 5.3 | 10.8 | 9.4 | 15.4 |
| Rasio Cepat | 1.9 | 5.2 | 10.7 | 9.3 | 15.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-56M | $-104M | $-111M | $-87M | $-86M |
Pemilik institusional (13F) 84 pengaju · $267.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
84
Nilai yang dipegang
$267.3M
Posisi baru
39
Posisi yang keluar
11
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 39 (+25 vs Kuartal sebelumnya) | 11 (+7 vs Kuartal sebelumnya) | 26 (+6 vs Kuartal sebelumnya) | 8 (-3 vs Kuartal sebelumnya) | +19.1M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $73.151.963 | 13.724.571 | 27,36% | Saham |
| BAKER BROS. ADVISORS LP | $53.959.982 | 10.123.824 | 20,19% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $34.516.451 | 6.475.882 | 12,91% | Saham |
| Soleus Capital Management, L.P. | $18.006.755 | 3.378.378 | 6,74% | Saham |
| Kynam Capital Management, LP | $12.872.414 | 2.415.087 | 4,82% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.710.342 | 2.009.445 | 4,01% | Saham |
| BlackRock, Inc. | $9.580.681 | 1.797.501 | 3,58% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $5.435.705 | 1.019.832 | 2,03% | Saham |
| TWO SIGMA INVESTMENTS, LP | $5.294.657 | 993.369 | 1,98% | Saham |
| ADAR1 Capital Management, LLC | $4.801.797 | 900.900 | 1,80% | Saham |
| MILLENNIUM MANAGEMENT LLC | $4.503.813 | 844.993 | 1,68% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $4.487.860 | 841.862 | 1,68% | Saham |
| VANGUARD GROUP INC | $4.100.559 | 1.413.986 | 1,53% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.083.286 | 766.095 | 1,53% | Saham |
| MORGAN STANLEY | $2.685.574 | 503.860 | 1,00% | Saham |
| STATE STREET CORP | $2.285.435 | 428.787 | 0,85% | Saham |
| UBS Group AG | $1.699.188 | 318.797 | 0,64% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.518.442 | 284.886 | 0,57% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.498.796 | 281.200 | 0,56% | Saham |
| NORTHERN TRUST CORP | $1.282.393 | 240.599 | 0,48% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.033.594 | 193.920 | 0,39% | Saham |
| MARSHALL WACE, LLP | $1.016.387 | 190.692 | 0,38% | Saham |
| TWO SIGMA ADVISERS, LP | $688.170 | 237.300 | 0,26% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $669.480 | 125.606 | 0,25% | Saham |
| GOLDMAN SACHS GROUP INC | $644.045 | 120.834 | 0,24% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $591.630 | 111.000 | 0,22% | Opsi beli |
| Hillsdale Investment Management Inc. | $433.862 | 81.400 | 0,16% | Saham |
| Bank of New York Mellon Corp | $363.436 | 68.187 | 0,14% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $360.425 | 67.622 | 0,13% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $343.785 | 64.500 | 0,13% | Saham |
| JANE STREET GROUP, LLC | $341.653 | 64.100 | 0,13% | Opsi beli |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $339.521 | 63.700 | 0,13% | Opsi jual |
| Squarepoint Ops LLC | $317.348 | 59.540 | 0,12% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $253.569 | 47.574 | 0,09% | Saham |
| Mariner, LLC | $241.241 | 45.261 | 0,09% | Saham |
| Nuveen, LLC | $197.333 | 37.023 | 0,07% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $186.839 | 35.210 | 0,07% | Saham |
| Invesco Ltd. | $185.175 | 34.742 | 0,07% | Saham |
| Cerity Partners LLC | $175.224 | 32.875 | 0,07% | Saham |
| State of Wyoming | $175.154 | 32.862 | 0,07% | Saham |
| CITADEL ADVISORS LLC | $166.829 | 31.300 | 0,06% | Opsi jual |
| Graham Capital Management, L.P. | $158.674 | 29.770 | 0,06% | Saham |
| DEUTSCHE BANK AG\ | $148.302 | 27.824 | 0,06% | Saham |
| WELLS FARGO & COMPANY/MN | $134.982 | 25.325 | 0,05% | Saham |
| BANK OF AMERICA CORP /DE/ | $127.254 | 23.875 | 0,05% | Saham |
| CITADEL ADVISORS LLC | $120.213 | 22.554 | 0,04% | Saham |
| RHUMBLINE ADVISERS | $117.649 | 22.074 | 0,04% | Saham |
| JANE STREET GROUP, LLC | $107.133 | 20.100 | 0,04% | Opsi jual |
| Vanguard Global Advisers, LLC | $86.399 | 16.210 | 0,03% | Saham |
| CITADEL ADVISORS LLC | $85.813 | 16.100 | 0,03% | Opsi beli |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×4 pengajuan | 23 April 2026 | 16,00% | Amandemen | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×6 pengajuan | 22 April 2026 | 15,50% | Amandemen | Struktur modal | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 11 pejabat · 7 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Krishna Vaddi | CEO | 4 Feb. 2026 A | 1.999.296 | 0 | 0 | $0 |
| Bryant David Lim | CLO, CFO, Corp Sec. | 4 Feb. 2026 A | 27.400 | 0 | 0 | $0 |
| Laurent Chardonnet | Chief Financial Officer | 1 Maret 2024 A | 42.165 | 0 | 0 | $0 |
| Brian Piper | Chief Financial Officer | 25 Agu 2021 M | 0 | 0 | 0 | $0 |
| Jane Huang | President, CMO | 4 Okt. 2025 M | 86.917 | 0 | 0 | $0 |
| Charles Q Morris | Chief Medical Officer | 1 Mei 2026 A | · | 0 | 0 | $0 |
| Andrew Combs | Chief Chemistry Officer | 4 Feb. 2026 A | 480.123 | 0 | 0 | $0 |
| Peggy Scherle | Chief Scientific Officer | 4 Feb. 2026 A | 172.920 | 0 | 0 | $0 |
| Deborah Morosini | EVP, Chief of Clinical Affairs | 15 Feb. 2022 A | 444 | 0 | 0 | $0 |
| David J Mauro | Chief Medical Officer | 5 Okt. 2021 M | 0 | 0 | 0 | $0 |
| Christopher Pierce | EVP and Chief of Business Oper | 2 Sep. 2021 M | 3.750 | 0 | 0 | $0 |
| Victor Sandor | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Katina Dorton | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| David P Bonita | Direktur | 9 Juni 2026 A | 1.126.126 | 2 | 0 | $12.499.998 |
| Martin Babler | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direktur | 9 Juni 2026 A | 500.098 | 0 | 0 | $0 |
| Mardi Dier | Direktur | 12 Juni 2025 A | 10.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 13 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 92.467 SH | 11 Sep. 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 19.546 SH | 2 Okt. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29.931 SH | 19 Agu 2026 | Harian |
| IWO · iShares Trust | 0,01% | 260.735 SH | 11 Sep. 2026 | Harian |
| IWM · iShares Trust | 0,00% | 694.659 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 13.254 NS | 31 Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.323 NS | 31 Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.414 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.348 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 458.355 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.513.825 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 160.484 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.505 SH | 19 Agu 2026 | Harian |
PRLD Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 9 analis
BELI
Target median
$10.00
+172,5%
3 33,3%
Beli Kuat
5 55,6%
Beli
1 11,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
5 analis · 2026-10-01Target rata-rata $9.20 +150,7%
← Di bawah semua target
Harga saat ini $3.67
Rendah$6.00
Rata-rata$9.20
Tinggi$12.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| RCKT | · | · | · | · | · | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026